We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QGTS:QSEQatar Gas Transport Co. Analysis

Data as of 2026-05-22 - not real-time

QAR 4.32

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Qatar Gas Transport (Nakilat) trades at a PE of 13.9, well below the industry average of 21.5, suggesting a clear valuation discount. The stock also offers an attractive dividend yield of 3.33% with a payout ratio near 46%, indicating reasonable sustainability given its solid operating margin of 40.9% and free cash flow generation. Revenue growth remains robust at 21% YoY, driven by LNG carrier demand, while gross margins hover around 74.6%, underscoring strong profitability. However, the balance sheet is heavily leveraged, with a debt‑to‑equity of 146.6 and total debt close to the market cap, posing a notable financial risk.
On the technical side, the price of QGTS sits just above the support level of 4.28 QAR and marginally below its 20‑day (4.35) and 50‑day (4.33) SMAs, reflecting a neutral price stance. The RSI of 47 indicates no clear overbought/oversold condition, while the MACD histogram is negative, hinting at short‑term bearish pressure. With a low beta of ~0.15 and modest 30‑day volatility of 17.9%, market‑related risk is limited, but the high leverage and regional geopolitical considerations warrant caution.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram signaling near‑term downside pressure
  • Price hovering just above technical support at 4.28 QAR
  • Attractive dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Strong 21% revenue growth driven by LNG transport demand
  • Undervalued PE relative to industry peers
  • Sustainable dividend payout supporting total return

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term charter contracts for LNG carriers ensuring stable cash flows
  • High operating margins and consistent free cash flow generation
  • Undervalued valuation offering upside potential despite leverage

Key Metrics & Analysis

Financial Health

Revenue Growth21.00%
Profit Margin41.80%
P/E Ratio13.9
ROE12.46%
ROA3.50%
Debt/Equity146.64
P/B Ratio1.7
Op. Cash FlowQAR2.4B
Free Cash FlowQAR125.0M
Industry P/E21.5

Technical Analysis

TrendNeutral
RSI47.1
SupportQAR 4.28
ResistanceQAR 4.45
MA 20QAR 4.35
MA 50QAR 4.33
MA 200QAR 4.57
MACDBearish
VolumeStable
Fear & Greed Index90.82

Valuation

Target PriceQAR 5.10
Upside/Downside18.15%
GradeUndervalued
TypeBlend
Dividend Yield3.33%

Risk Assessment

Beta0.15
Volatility17.87%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.